Scientific article
OA Policy
English

QT prolongation alerts lead to monitoring but rarely to therapeutic changes : a prospective hospital study

Published inFrontiers in pharmacology, vol. 17, 1833921
First online date2026-05-07
Abstract

Introduction : Drug-induced QT interval prolongation is a well-recognized safety concern in hospitalized patients. Clinical decision support systems (CDSS) generate alerts to identify high-risk drug combinations, but their impact on clinical management remains uncertain.

Methods : This study evaluated clinical responses from prescribing clinicians to QT prolongation alerts, focusing on electrocardiogram (ECG) monitoring and treatment modifications. We conducted a 10-month prospective study in two hospital wards (acute geriatrics and orthopedics) at Geneva University Hospitals. The CDSS embedded within the electronic health record used a pharmacodynamic risk scoring system (Riskbase) that assigns scores to individual drugs based on pharmacological and clinical evidence and generates alerts when cumulative risk exceeds a predefined threshold. Clinical interventions were assessed within 7 days following high-risk QT alerts.

Results : A total of 154 patients were included (123 in geriatrics and 31 in orthopedics). Intervention rates ranged from 60.2% to 91.9% in geriatrics and from 45.2% to 80.6% in orthopedics, depending on the time window. However, these interventions were almost exclusively driven by ECG monitoring. Treatment modifications were rare, occurring in only 2.0% of patients. Most alerts were associated with combinations of low- or moderate-risk drugs, particularly antipsychotics, antidepressants, and antiemetics, some of which may have alternatives with lower QT-prolongation potential and may be considered depending on the clinical context. In addition, medications prescribed on an as-needed basis contributed substantially to QT risk scores, despite limited recent administration.

Discussion : In clinical practice, QT prolongation alerts are associated with frequent monitoring but rarely lead to therapeutic changes. These findings highlight a gap between risk identification and pharmacological risk mitigation and suggest opportunities to improve medication safety through more targeted prescribing and optimization of alert systems.

Keywords
  • QT prolongation
  • Alert fatigue
  • Clinical decision support system
  • Medication safety
  • Patient safety
  • Pharmacodynamic alerts
Citation (ISO format)
SIMONA, Aurélien et al. QT prolongation alerts lead to monitoring but rarely to therapeutic changes : a prospective hospital study. In: Frontiers in pharmacology, 2026, vol. 17, p. 1833921. doi: 10.3389/fphar.2026.1833921
Main files (1)
Article (Published version)
Secondary files (2)
Supplemental data
accessLevelPublic
Supplemental data
accessLevelPublic
Identifiers
Journal ISSN1663-9812
13views
34downloads

Technical informations

Creation07/05/2026 09:54:30
First validation26/05/2026 09:46:25
Update26/05/2026 09:46:25
Status update26/05/2026 09:46:25
Last indexation26/05/2026 09:46:26
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack